Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 13, 2026 at 7:51 PM
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 12, 2026 at 7:51 PM
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
🚨 $BLFS
Ellingson Rachel (Insider) reported special transactions (Non-P/S).
Ellingson Rachel (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 2:00 AM
🚨 $BLFS
Ellingson Rachel (Insider) reported special transactions (Non-P/S).
Ellingson Rachel (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
GOSWAMI JOYDEEP (Insider) reported special transactions (Non-P/S).
GOSWAMI JOYDEEP (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 2:00 AM
🚨 $BLFS
GOSWAMI JOYDEEP (Insider) reported special transactions (Non-P/S).
GOSWAMI JOYDEEP (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
DuRoss Amy (Insider) reported special transactions (Non-P/S).
DuRoss Amy (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:59 AM
🚨 $BLFS
DuRoss Amy (Insider) reported special transactions (Non-P/S).
DuRoss Amy (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
Coste Catherine (Insider) reported special transactions (Non-P/S).
Coste Catherine (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:59 AM
🚨 $BLFS
Coste Catherine (Insider) reported special transactions (Non-P/S).
Coste Catherine (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
Hunt Anthony (Insider) reported special transactions (Non-P/S).
Hunt Anthony (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:58 AM
🚨 $BLFS
Hunt Anthony (Insider) reported special transactions (Non-P/S).
Hunt Anthony (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
MOORE TIMOTHY L. (Insider) reported special transactions (Non-P/S).
MOORE TIMOTHY L. (Insider) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:58 AM
🚨 $BLFS
MOORE TIMOTHY L. (Insider) reported special transactions (Non-P/S).
MOORE TIMOTHY L. (Insider) reported special transactions (Non-P/S).
🚨 $BLFS
Wichterman Troy (Chief Financial Officer) reported special transactions (Non-P/S).
Wichterman Troy (Chief Financial Officer) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 2:00 AM
🚨 $BLFS
Wichterman Troy (Chief Financial Officer) reported special transactions (Non-P/S).
Wichterman Troy (Chief Financial Officer) reported special transactions (Non-P/S).
🚨 $BLFS
Berard Todd (Chief Marketing Officer) reported special transactions (Non-P/S).
Berard Todd (Chief Marketing Officer) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:56 AM
🚨 $BLFS
Berard Todd (Chief Marketing Officer) reported special transactions (Non-P/S).
Berard Todd (Chief Marketing Officer) reported special transactions (Non-P/S).
🚨 $BLFS
Werner Sean (Chief Technology Officer) reported special transactions (Non-P/S).
Werner Sean (Chief Technology Officer) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:55 AM
🚨 $BLFS
Werner Sean (Chief Technology Officer) reported special transactions (Non-P/S).
Werner Sean (Chief Technology Officer) reported special transactions (Non-P/S).
🚨 $BLFS
DE GREEF RODERICK (Chief Executive Officer) reported special transactions (Non-P/S).
DE GREEF RODERICK (Chief Executive Officer) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:59 AM
🚨 $BLFS
DE GREEF RODERICK (Chief Executive Officer) reported special transactions (Non-P/S).
DE GREEF RODERICK (Chief Executive Officer) reported special transactions (Non-P/S).
🚨 $BLFS
Mathew Aby J. (EVP & Chief Scientific Officer) reported special transactions (Non-P/S).
Mathew Aby J. (EVP & Chief Scientific Officer) reported special transactions (Non-P/S).
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 9, 2026 at 1:58 AM
🚨 $BLFS
Mathew Aby J. (EVP & Chief Scientific Officer) reported special transactions (Non-P/S).
Mathew Aby J. (EVP & Chief Scientific Officer) reported special transactions (Non-P/S).
▬ $BLFS BioLife Solutions : Multiple officers (CEO DE GREEF $14.1M, CFO Wichterman $3.7M, CTO Werner $2.75M, CSO Mathew $2.7M, CMO Berard $1.78M) had shares withheld for taxes at $38.61 alongside new awards, and directors Goswami, Ellingson, DuRoss, Coste...
October 9, 2026 at 12:00 PM
▬ $BLFS BioLife Solutions : Multiple officers (CEO DE GREEF $14.1M, CFO Wichterman $3.7M, CTO Werner $2.75M, CSO Mathew $2.7M, CMO Berard $1.78M) had shares withheld for taxes at $38.61 alongside new awards, and directors Goswami, Ellingson, DuRoss, Coste...
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 8, 2026 at 7:51 PM
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 7, 2026 at 7:51 PM
Profit BLFS: +0.2% (+$0.21). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
$BLFS — Delisting Notice
BIOLIFE SOLUTIONS INC (BLFS) received a delisting notice from Nasdaq Stock Market LLC, filed as a Form 25-NSE on October 6, 2026, effective the same date. The delisting is pursuant to Rule 17 CFR 240.12d2-2(a)(3), indicating the company's securities were d...
🧵 continued ↓
BIOLIFE SOLUTIONS INC (BLFS) received a delisting notice from Nasdaq Stock Market LLC, filed as a Form 25-NSE on October 6, 2026, effective the same date. The delisting is pursuant to Rule 17 CFR 240.12d2-2(a)(3), indicating the company's securities were d...
🧵 continued ↓
October 6, 2026 at 6:46 PM
$BLFS — Delisting Notice
BIOLIFE SOLUTIONS INC (BLFS) received a delisting notice from Nasdaq Stock Market LLC, filed as a Form 25-NSE on October 6, 2026, effective the same date. The delisting is pursuant to Rule 17 CFR 240.12d2-2(a)(3), indicating the company's securities were d...
🧵 continued ↓
BIOLIFE SOLUTIONS INC (BLFS) received a delisting notice from Nasdaq Stock Market LLC, filed as a Form 25-NSE on October 6, 2026, effective the same date. The delisting is pursuant to Rule 17 CFR 240.12d2-2(a)(3), indicating the company's securities were d...
🧵 continued ↓
Loss BLFS: -0.8% ($-0.96). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 6, 2026 at 7:51 PM
Loss BLFS: -0.8% ($-0.96). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
$RGEN — Merger/Acquisition
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
October 6, 2026 at 4:45 PM
$RGEN — Merger/Acquisition
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
Repligen Corporation (RGEN) completed its acquisition of BioLife Solutions, Inc. (BLFS), a cell processing tools and services provider for the cell and gene therapy market.
🧵 continued ↓
🚨 $BLFS
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 6, 2026 at 2:45 PM
🚨 $BLFS
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
🚨 $BLFS
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
SEC Filing: BLFS
Click to view the official SEC document.
www.sec.gov
October 6, 2026 at 1:12 PM
🚨 $BLFS
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
The information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time of the First Merger , each share of BioLife’s common stock, par value $0.001 per share , issued and outstanding immediately prior ...
$BLFS — Merger/Acquisition
BioLife Solutions, Inc. filed an Amended and Restated Certificate of Incorporation with the State of Delaware on October 6, 2026, in connection with the completion of an acquisition or disposition.
🧵 continued ↓
BioLife Solutions, Inc. filed an Amended and Restated Certificate of Incorporation with the State of Delaware on October 6, 2026, in connection with the completion of an acquisition or disposition.
🧵 continued ↓
October 6, 2026 at 4:32 PM
$BLFS — Merger/Acquisition
BioLife Solutions, Inc. filed an Amended and Restated Certificate of Incorporation with the State of Delaware on October 6, 2026, in connection with the completion of an acquisition or disposition.
🧵 continued ↓
BioLife Solutions, Inc. filed an Amended and Restated Certificate of Incorporation with the State of Delaware on October 6, 2026, in connection with the completion of an acquisition or disposition.
🧵 continued ↓
Trading Halted for $BLFS BioLife Solutions Inc Cmn Stk | at 19:50:00.000 ET on NASDAQ | Halt - Additional Information Requested by NASDAQ | 2026-10-05
October 5, 2026 at 11:51 PM
Trading Halted for $BLFS BioLife Solutions Inc Cmn Stk | at 19:50:00.000 ET on NASDAQ | Halt - Additional Information Requested by NASDAQ | 2026-10-05
Profit BLFS: +0.4% (+$0.48). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
October 5, 2026 at 7:51 PM
Profit BLFS: +0.4% (+$0.48). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
Loss BLFS: -1.2% ($-1.35). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet
September 29, 2026 at 7:50 PM
Loss BLFS: -1.2% ($-1.35). Exit: reversi ke MA10 (short). US-stock mean-reversion paper sim, not advice.
https://palugadahub.com/wallstreet
https://palugadahub.com/wallstreet